Marie-pierre P. Pinchart-Brenier
Grenoble, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 69 publications
Diagnosis and treatment of congenital toxoplasmosis: an updated overview.
Journal: Expert review of anti-infective therapy
Published: May 11, 2026
Photo Quiz: Hidden travelers and visible marks-about two imported dermatological cases in Grenoble, France.
Journal: Journal of clinical microbiology
Published: November 12, 2025
Multicenter performance evaluation of the "quanty TOXO (RH region)" kit (Clonit) for molecular diagnosis of toxoplasmosis.
Journal: Journal of clinical microbiology
Published: October 09, 2025
New evaluation of the Toxoplasma ELITe MGB assay on the ELITe Ingenius™ platform (ELITechGroup).
Journal: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
Published: June 25, 2025
Structural and functional characterization of TgGSK3, a druggable kinase in Toxoplasma gondii.
Journal: Nature communications
Published: January 20, 2025
Uncovering biomarkers for chronic toxoplasmosis detection highlights alternative pathways shaping parasite dormancy.
Journal: EMBO molecular medicine
Published: December 04, 2024
Multicenter evaluation of the Toxoplasma gondii Real-TM (Sacace) kit performance for the molecular diagnosis of toxoplasmosis.
Journal: Journal of clinical microbiology
Published: March 12, 2024
Toxoplasma gondii, a plea for a thorough investigation of its oncogenic potential.
Journal: Heliyon
Published: June 19, 2023
Correction: A systematic review and an individual patient data meta-analysis of ivermectin use in children weighing less than fifteen kilograms: Is it time to reconsider the current contraindication?
Journal: PLoS neglected tropical diseases
Published: January 06, 2023
A Trichinella britovi outbreak in the Northern Alps of France: investigation by a local survey network.
Journal: Parasite (Paris, France)
Published: September 02, 2022
Altiratinib blocks Toxoplasma gondii and Plasmodium falciparum development by selectively targeting a spliceosome kinase.
Journal: Science translational medicine
Published: August 03, 2022
Last Updated: 09/26/2026